NeuroPace (NPCE) Non Operating Interest Expenses (2020 - 2026)

For the trailing twelve months through Sep 30, 2026, Non Operating Interest Expenses at NeuroPace was $6.23 million, down 22.7% year-over-year; for FY2025, it came in at $7.46 million, down 15.2% from FY2024.

• Annual Non Operating Interest Expenses shows a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
• In prior years, NeuroPace's Non Operating Interest Expenses was $8.8 million in FY2024 (+3.3%), $8.52 million in FY2023 (+13.1%), $7.53 million in FY2022 (+1.6%) and $7.41 million in FY2021 (-35.5%).
• Quarterly Non Operating Interest Expenses has run from a low of $1.52 million in Q1 2026 to a high of $2.26 million in Q1 2024 over five years.
• On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last nine quarters, with an average decline of 15.3% over the last eight quarters.
• The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q4 2023, with growth of 15.2%; the weakest was Q1 2026, with a decline of 29.4%.
• According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $1.54 million (Q2 2026), $1.52 million (Q1 2026) and $1.6 million (Q4 2025).